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Development of the nephron tubules, the functional units of the kidney, requires the differentiation of a
renal progenitor population of mesenchymal cells to epithelial cells. This process requires an intricate
balance between self-renewal and differentiation of the renal progenitor pool. Sall1 is a transcription
factor necessary for renal development which is expressed in renal progenitor cells (cap mesenchyme).
Sall1 recruits the Nucleosome Remodeling and Deacetylase (NuRD) chromatin remodeling complex to
regulate gene transcription. We deleted Mi2b, a component of the NuRD complex, in cap mesenchyme
(CM) to examine its role in progenitor cells during kidney development. These mutants displayed
signiﬁcant renal hypoplasia with a marked reduction in nephrons. Markers of renal progenitor cells, Six2
and Cited1 were signiﬁcantly depleted and progenitor cell proliferation was reduced. We also demon-
strated that Sall1 and Mi2b exhibited a strong in vivo genetic interaction in the developing kidney.
Together these ﬁndings indicate that Sall1 and NuRD act cooperatively to maintain CM progenitor cells.
Published by Elsevier Inc.Introduction
Formation of the kidney requires a delicate balance between
progenitor cell self-renewal and differentiation. These opposing
forces are initiated by invasion of the ureteric bud (UB) into the
metanephric mesenchyme (MM) at mouse embryonic (E) day
10.5 and continue until nephrogenesis ceases. If this balance is
disrupted so that growth is impaired, then the kidney will not
achieve the full complement of nephrons (renal hypoplasia), the
tubules that comprise the functional units of this organ. Renal
hypoplasia is a common cause of childhood kidney failure and can
lead to hypertension in otherwise asymptomatic adults (Keller
et al., 2003). Conversely, if progenitor cell proliferation is uncon-
trolled and differentiation is arrested, Wilms’ tumor, an embryonic
tumor of the kidney results (Kreidberg and Hartwig, 2008).
Recent gene expression studies have reﬁned our understanding
of the renal progenitor compartment (Boyle et al., 2008; Kobayashi
et al., 2008). These important studies demonstrate that Six2 and
Cited1 deﬁne a population of self-renewing progenitors that aggre-
gate around the tips of the UB, called ‘‘cap’’ mesenchyme (CM).
These CM cells are induced to undergo the ﬁrst step in forming theInc.
istry and Molecular Biology,
r, 1100 S. Grand Blvd.,
),tubular segments of the nephron via a mesenchymal- to-epithelial
transition, giving rise to the renal vesicle (Costantini and Kopan,
2010; Dressler, 2009). As kidney development proceeds, the UB
undergoes branching morphogenesis and induces CM at each tip, an
iterative process that gives rise to the 10–12,000 nephrons in a
mouse kidney or 500,000 in humans (Puelles et al., 2011). At the
same time, a subset of CM cells proliferates to maintain the
progenitor pool until an appropriate number of nephrons is formed
and nephrogenesis is complete. Numerous studies using genetically
engineered mice, metanephric organ culture and other model
organisms have identiﬁed genes that regulate the maintenance
and expansion of renal progenitors or promote differentiation
(Dressler, 2009). However, the molecular mechanisms that regulate
cell fate decisions to balance these processes throughout the period
of nephron formation are incompletely understood.
Balancing the timely induction of differentiation versus prolifera-
tion and growth of renal progenitors requires tight regulation of gene
expression programs. This is accomplished by the coordinated action
of sequence speciﬁc transcription factors and enzymes that modify
chromatin, thereby regulating DNA accessibility for transcription
of speciﬁc genes. Sall1 encodes a multi-zinc ﬁnger transcription
factor essential for kidney development as its genetic deﬁciency
results in bilateral renal agenesis or severe hypodysplasia in mice
(Nishinakamura et al., 2001). Mutations in human SALL1 cause the
autosomal dominant Townes–Brocks Syndrome which is character-
ized by multi-organ defects including renal hypoplasia, deafness,
limb deformities and imperforate anus (Kohlhase et al., 1998).
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progenitor cells that give rise to all segments of the nephron, except
the UB-derived collecting ducts and the mesangial and endothelial
cells of the glomeruli (Osafune et al., 2006). Unlike Six2, Sall1
expression is maintained in renal vesicles, and comma- and S-
shaped bodies, structures that are precursors of the mature neprhon
epithelial tubules. Sall1 deﬁcient CM is competent to differentiate
into nephrons in vitro, but colony sizes are signiﬁcantly reduced
compared with wild type renal progenitors (Osafune et al., 2006).
This suggests that Sall1 is required to maintain or expand progenitor
cells rather than providing an instructive signal for differentiation.
However, the molecular mechanism by which Sall1 maintains renal
progenitor cells is not known.
Proteins that act on chromatin are thought to be recruited to
speciﬁc genomic regions by sequence speciﬁc DNA binding
factors. Sall1 is a potent transcriptional repressor that interacts
with the Nucleosome Remodeling and Deacetylase (NuRD) com-
plex via a conserved 12-amino acid motif to regulate gene
expression (Kiefer et al., 2002; Lauberth et al., 2007; Lauberth
and Rauchman, 2006). NuRD is a multi-protein complex that
contains both histone deacetylase (HDAC) activity and ATP-
dependent nucleosome remodeling activity due to Mi2b. Recent
studies establish a role for NuRD in embryonic stem (ES) cell
pluripotency (Kaji et al., 2006; Reynolds et al., 2012) and in
differentiation of progenitor cells in complex self-renewing epithelia
(e.g. skin) and in the hematopoetic system (Kashiwagi et al., 2007;
Yoshida et al., 2008). Speciﬁcally, Mi2b is a key regulator of
progenitor cell self-renewal and multi-lineage restriction of hemato-
poetic stem cells and T lymphocytes (Williams et al., 2004). Evidence
that Sall1 and NuRD interact to regulate gene expression led us to
hypothesize an important role for Mi2–NuRD during kidney devel-
opment. To test this we examined the consequences ofMi2b deletion
in CM renal progenitors, a cell population that also expresses Sall1.
We deleted Mi2b in CM cells and show that these mutants
displayed signiﬁcant renal hypoplasia with a marked reduction in
nephrons. Proteins which are expressed in renal progenitor cells,
Six2, Cited1, and Pax2 were signiﬁcantly depleted and progenitor
cell proliferation was reduced. We found that Sall1 and Mi2b
exhibited a strong in vivo genetic interaction in the developing
kidney. Together these ﬁndings indicate that Sall1 and NuRD act
cooperatively to maintain CM progenitor cells.Materials and methods
Mouse strains
The Six2Cre:GFPTg/þ BAC transgenic strain, conditionalMi2bﬂ/ﬂ,
and Sall1þ / mice have been described previously (Kobayashi
et al., 2008; Nishinakamura et al., 2001; Williams et al., 2004).
Double heterozygous Six2Cre:GFPTg/þ , Mi2bﬂ/þ male mice were
mated to Mi2bﬂ/ﬂ and Sall1þ /Mi2bﬂ/ﬂ female mice to create
Mi2bD/D, Sall1þ /Mi2bD/þ , and Sall1þ /Mi2bD/D mutant embryos.
Wild type ICR/CD-1 (Harlan) mice were used for co-
immunoprecipitation assays. Female mice were checked for pre-
sence of a mucosal plug and noon on the day of detection was
considered to be E0.5. Pregnant females were euthanized at the
appropriate developmental stages and a C-section was performed
to remove embryos. These studies were performed under the
auspices of St. Louis University and St. Louis VA Medical Center
animal care guidelines.
Quantitative real-time PCR
RNA was isolated from embryonic kidneys at E12.5 using the
RNeasy RNA isolation kit (Qiagen) according to the manufacturer’sprotocol. cDNA was prepared using the High Capacity RNA-to-cDNA
kit (InVitrogen) and sequence-speciﬁc PCR primer sets were
designed by Primer Express 3.0 (PE Applied Biosystems). qPCR
analyses of NuRD componentsMta 1/2/3,Mbd 2/3, andMi2 a/b was
performed using a 7300 Real-Time PCR Instrument and SYBR Green
reagent (Applied Biosystems). The thermal cycling parameters were
as follows: 50 1C for 2 min, 95 1C for 10 min, 40 cycles of 15 s at
95 1C, and 1 min at 60 1C. The dissociation curve for each primer
pair conﬁrmed a single reaction product. Reactions were performed
in triplicate using samples from three independent embryos. The
amount of each ampliﬁcation product was determined relative to a
standard curve of input cDNA. The following primer sets were used
for qPCR analysis: Mta1 (50-CGTGCTCCGGTATCTTGAG-30 and 50-CG
CTTCTTCATGTTGCCATC-30), Mta2 (50-TTTCCGGCGAAGGGATATTTC-
30 and 50-GCTTCAGTTGATGTCTCTGCT-30), Mta3 (50-CCCAGAGCGCC
CTCCTA-30 and 50-CTCTGCAGTCGGGCTGG-30), Mbd2 (50-GAAGAAG-
GAGGAAGTGATCCG-30 and 50-ACTAGGCATCATCTTGCCG-30), Mbd3
(50-GGAAAGGGAAGAAGTGCCC-30 and 50-GTTCATCAACATCTTTCC
GGT-30),Mi2a (50-CCGCACTATGCGGAGATC-30 and 50-TCTGGATGTT-
CATCTCATCC-30), and Mi2b (50-CCTAAGTTTGCAGAGATGGAAGA-30
and 50-TCCTGAATCTCCACGTCCTG-30).
Tissue section analysis
E12.5–16.5 kidneys were ﬁxed, sectioned, and stained with
Hematoxylin and Eosin as described previously (Kiefer et al.,
2003). Immunoﬂuorescence was performed on 10 mm frozen
sections using rabbit anti-Sall1(Kiefer et al., 2002), mouse anti-
Mi2b (1:500, Abcam), mouse anti-NCAM (1:300, Abcam), rabbit
anti-WT1 (1:1000, Santa Cruz) biotin -LTL (1:200, Vector), rat
anti-E-cadherin (1:1000, Abcam), rabbit anti-pHH3 (1:1000,
Fisher), rabbit anti-Cited1 (1:500, Abcam), rabbit anti-Six2
(1:500, Lifespan Biosciences), rabbit anti-Pax2 (1:2000, Covance),
rabbit anti-Lef1 (1:250, Cell Signaling), mouse anti-Lhx1 (1:50,
Developmental Studies Hybridoma Bank) and mouse anti-
cytokeratin (1:1000, Lifespan Biosciences). Antibody reactivity
was detected using Alexa 488-labeled anti-rabbit (1:400, Invitro-
gen), Cy3-labeled anti-rat (1:2000, Jackson ImmunoResearch) or
Cy3-labeled anti-mouse (1:2000, Jackson ImmunoResearch), and
mounted in Mowiol (Polysciences) as previously described (Kiefer
et al., 2002). Sections were incubated without primary antibody
to control for non-speciﬁc staining of secondary antibodies.
10 mm frozen sections were also used for analysis of apoptosis
using the ApopTag Red In Situ Apoptosis Detection kit (Millipore)
according to the manufacturer’s protocol.
Whole mount immunoﬂuoresence and in situ hybridization
E12.5 kidneys were dissected as described above from wild
type and Mi2bD/D mice and ﬁxed for 30 min in 4% PFA. Kidneys
were blocked in PBS plus 1% Triton and then incubated overnight
at 4 1C in primary antibody mouse anti-cytokeratin (1:400).
Kidneys were washed and probed with secondary anti-mouse
Cy3 (1:1000). Whole-mount in situ hybridization was performed
using a digoxigenin-labeled antisense riboprobe for Ret (nucleo-
tides 818-1222) as previously described (Kiefer et al., 2008). After
incubation with digoxigenin-alkaline phosphatase antibody
(1:2500), signal was visualized using the alkaline phosphatase
substrate BM purple (Roche, Indianapolis, IN, USA).
Quantiﬁcation of UB branching
10 mm sections of wild type and Mi2bD/D kidneys harvested
from three independent embryos at E12.5, E13.5, E14.5, and E15.5
were immunostained for cytokeratin. Total UB tips were counted
on at least ﬁve 20X sections from each kidney for each stage and
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per section. Statistical analysis using standard t test was
performed.Quantiﬁcation of proliferation and apoptosis
10 mm sections of kidneys from two independent wild type
and Mi2b mutant embryos at E12.5, 13.5, and 14.5 were co-
stained with anti-Sall1 and anti-pHH3 as stated above. Double
Sall1/pHH3-positive cells surrounding UB tips were counted and
related to the total number of Sall1-positive cells surrounding
that tip. Results are reported as the percentage of double Sall1/
pHH3-positive cells divided by the total number of Sall1-positive
cells7SD.Results
The nucleosome remodeling and deacetylase complex is expressed in
the developing kidney
The Mi2/NuRD complex is a multi-protein complex that regulates
transcriptional activation or repression through its actions on chro-
matin (Xue et al., 1998; Zhang et al., 1999). It is made up of histone
deacetylases (HDAC) 1/2, retinoblastoma associated proteins (RbAp)
46/48, methyl CpG binding domain (MBD) proteins 2/3, metastasis
tumor associated (Mta) proteins 1/2/3, and chromodomain-helicase-
DNA-binding (CHD) protein 3/4, also known and referred to here as
Mi2 a and b (Fig. 1A). The NuRD complex components are evolutio-
narily conserved and broadly expressed in many tissue types
(McDonel et al., 2009). However, several of its components (Mbd,
Mta, and Mi2) exist as multiple isoforms that form distinct com-
plexes with non-overlapping functions (Bowen et al., 2004). We thus
determined which components are expressed in the developing
kidney. We examined the mRNA levels of Mta 1/2/3, Mi2 a/b, and
Mbd 2/3 in E12.5 wild-type kidneys by RT-PCR. Mta 1, 2, and 3, and
Mbd 2 and 3 were expressed at similar levels relative to the
housekeeping gene ribosomal protein L19 (Rpl19). Only one isoform
of Mi2 (Mi2b) was expressed at relatively high levels (Fig. 1B).
RbAp46/48, Hdac1/2, and p66 have previously been shown to be
expressed in the developing kidney (Chen et al., 2011; Guan et al.,
1998); therefore all NuRD components are expressed, except Mi2a,
allowing for the existence of multiple unique NuRD complexes;
however the only ATPase component is Mi2b.Fig. 1. Nucleosome remodeling and deacetylase complex is expressed in the develop
componentsMta 1/2/3,Mbd 2/3, andMi2 a/bwere measured in E12.5 kidneys. (C–D) Imm
detected in CM in wild type (C) kidneys. In Six2-Cretg/þ ,Mi2bﬂ/ﬂ mutants (D), Mi2b prote
and its derivative structures.Conditional deletion of Mi2b from cap mesenchyme results in renal
hypoplasia
Mi2b was detected in all compartments of the kidney including
the population of self-renewing renal progenitors in the cap
mesenchyme [CM] (Fig. 1C). Since Mi2–NuRD has been implicated
in regulating differentiation of progenitor cells in the hemato-
poetic system (Yoshida et al., 2008), we hypothesized that Mi2b
would be required in renal progenitor cells. To test this, we used a
Six2-Cre:GFP BAC transgenic mouse (Six2Cre) to speciﬁcally delete
Mi2b from the CM (Kobayashi et al., 2008). Expression of the Six2
transgene is restricted to the CM cells and pre-tubular aggregates
which give rise to all epithelial components of the nephron
segments except collecting ducts (Kobayashi et al., 2008; Oliver
et al., 1995).
Deletion of Mi2b using Cre recombinase under control of the
Six2 promoter was efﬁcient as shown by marked reduction of
Mi2b protein expression in the CM cells surrounding the UB tips
(Fig. 1C, D). Reduced expression was also observed in forming
renal vesicles and further differentiated structures such as
comma- and S-shaped bodies that are derived from CM (data
not shown). UB expression of Mi2b was not affected conﬁrming
that the Six2Cre transgene is speciﬁcally active in the CM.
We analyzed kidneys in which Mi2b was deleted from the CM
at several stages of embryonic development. There were no
signiﬁcant differences observed at E12.5–13.5 (Fig. 2A–D).
Kidneys of both wild-type and Mi2bD/Dmice were similar in size
and Six2-positive cap mesenchyme formed as marked by GFP
expression from the Six2 transgene. However, at E14.5, kidneys
were signiﬁcantly hypoplastic (27/30 kidneys; n¼15 embryos)
compared to wild-type littermates (Fig. 2E, F). Additionally, GFP
expression was reduced in Mi2bD/D kidneys at E14.5, suggesting a
decrease in the number of Six2-positive CM cells at this stage
(Fig. 2E, F). To quantify hypoplasia, we calculated the area of the
kidney by measuring the width and height and related this to the
overall weight of the embryo. The average kidney size to body
weight ratio for Mi2bD/D mice (38.075.95) was signiﬁcantly
smaller (po0.001) than that of wild-type kidneys (56.577.27)
(Fig. 2G). Body weights for wild-type and homozygous mutants
were identical for all stages examined, conﬁrming that the renal
hypoplasia was not due to developmental delay affecting the
overall growth of the embryo (Fig. 2H).
To quantify branching, we counted the number of UB tips
per section identiﬁed by cytokeratin immunostaining at E12.5–15.5
(Fig. 3C). There was no signiﬁcant (p¼0.27) difference in the
average number of tips per section for wild type and Mi2bD/Ding kidney. (A) Schematic of the NuRD components. (B) mRNA levels of NuRD
unoﬂuorescence analysis of Mi2b in E13.5 wild type andMi2bD/D kidneys. Mi2b is
in expression was signiﬁcantly and speciﬁcally reduced in CM surrounding UB tips
Fig. 2. Deletion of Mi2b from cap mesenchyme cells results in renal hypoplasia.
(A–F) Whole kidney images of GFP expressed from the Cre:GFP fusion protein
under control of the Six2 BAC transgene in wild type andMi2bD/D embryos at E12.5
(A, B), E13.5 (C, D), and E14.5 (E, F). Both wild type and Mi2bD/D kidneys were
similar in size at E12.5 and E13.5 (A–D). Hypoplasia and reduction of GFP
expression was evident at E14.5 in Mi2bD/D kidneys compared to wild type
littermates (E, F). (G) Quantiﬁcation of hypoplasia by relating kidney area to body
weight of the embryo over a developmental stage period of E13.5 to E18.5.
Deletion of Mi2b resulted in renal hypoplasia in 90% of mutants with an average
33% reduction in the area/body weight ratio. (H) Average body weights of wild-
type and Mi2bD/D embryos. Body weights of wild type (black bars) and Mi2bD/D
mutant (white bars) embryos were indistinguishable throughout development.
Fig. 3. Ureteric bud branching is not altered at early stages in Mi2bD/D kidneys.
(A–D) Immunostaining of the UB with cytokeratin. At E12.5 and E13.5 UB
branching was similar in wild type (A, C) and Mi2bD/D (B, D) kidneys. (E and F)
Whole mount in situ hybridization of Ret in E15.5 wild type (E) and Mi2bD/D
(F) kidneys. Ret expression at UB tips is preserved in Mi2bD/D kidneys. (G)
Quantiﬁcation of UB branching as measured by tip counting of sections from
E12.5–E15.5 wild type (black bars) andMi2bD/D (white bars) kidneys. At E12.5 and
E13.5, there was no signiﬁcant difference (p¼0.27) in the average number of UB
tips per section in wild type (470.45 and 670.87) and Mi2bD/D (470.55 and
670.71). A signiﬁcant reduction (po0.001) in the average number of UB tips
per section was observed in Mi2bD/D kidneys compared to wild type kidneys at
E14.5 (872.12 vs. 1172.12) and E15.5 (1271.67 vs. 1871.48).
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670.71). However, there was a signiﬁcant (po0.001) reduction
in the average number of UB tips per section at E14.5 in Mi2bD/D
mutants compared to the wild type (872.12 vs. 1172.25) and
E15.5 (1271.67 vs. 1871.48). At E15.5, when Mi2bD/D kidneys
are notably hypoplastic, expression of Ret mRNA at UB tips was
unchanged in mutant kidneys (Fig. 3D, E). Together, these results(Figs. 2 and 3) show that renal hypoplasia is ﬁrst apparent in
the Mi2bD/D mutant at E14.5. At this stage, there is depletion of
Six2-positive CM and reduced UB branching. Because reduced UB
branching could be secondary to loss of CM, we hypothesized that
defects in the CM prior to E14.5 represent the primary cause of
the phenotype.
Renal progenitor cells are depleted in Mi2b mutants
To further investigate the mechanism of renal hypoplasia, we
examined several proteins known to be expressed in the renal
progenitor cells. We analyzed the expression of Cited1 and Six2,
two genes speciﬁc for the proliferating progenitor population (CM)
of the developing kidney, at both E12.5 and E14.5. Six2 is also
expressed in pre-tubular aggregates (Self et al., 2006), while Cited1
expression is restricted to a subpopulation of Six2-expressing cap
mesenchyme cells that constitute the self-renewing progenitors,
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(Plisov et al., 2005). Pax2 is expressed in CM, early differentiating
epithelial structures, and the branching ureteric bud epithelium
(Dressler et al., 1990). Sall1 is highly expressed in CM cells and its
expression persists in differentiating structures (Nishinakamura
et al., 2001).
At E12.5, Cited1 was expressed in the cap mesenchyme
surrounding UB tips in wild-type kidneys (Fig. 4A), however, it
was not detected in Mi2bD/D kidneys (Fig. 4B). Six2 was expressed
in both wild-type and Mi2bD/D kidneys in CM, indicating that CM
does indeed initially form in these mutant kidneys (Fig. 4C, D),
consistent with preserved GFP expression from Six2Cre in the
mutant (Fig. 2B). Pax2 was also expressed in cap mesenchyme
as well as branching UB in both wild-type and Mi2bD/D kidneys
(Fig. 4E, F). Like Six2 and Pax2, Sall1 expression was maintained inFig. 4. Progenitor cell markers are decreased in Mi2b mutants. Immunoﬂuorescence an
Pax2 (E, F, M, N), and Sall1 (G, H, O, P). (A, B, I, and J) Cited1 was expressed in CM cells su
detected inMi2bD/D kidneys at either developmental stage (B, J). (C, D, K, and L) At E12.5
kidneys (C, D), however there was a marked reduction in the number of Six2-positive c
immunostaining was detected in ureteric bud (UB) branches as well as CM cells at E12.5
in E14.5 wild type and Mi2bD/D kidneys, however there were fewer Pax2-positive cells s
(G, H, O, and P) Sall1 expression was evident in CM cells surrounding UB tips in both wild
reduction in the number of Sall1-positive cells surrounding UB tips in E14.5 Mi2bD/D kthe CM cells of Mi2b mutant kidneys compared to wild type
kidneys (Fig. 4G, H). Thus, while expression of several proteins
was preserved in CM at E12.5, Cited1 was markedly reduced,
suggesting a defect in CM prior to when renal hypoplasia is
evident.
At E14.5, both Cited1 and Six2 continued to be expressed in
the cap mesenchyme surrounding UB tips in wild-type tissues
(Fig. 4I, K). In Mi2b mutants, Cited1 expression remained unde-
tectable in these cells (Fig. 4J). Six2 expression was reduced
overall and the number of Six2-positive CM cells was diminished
(Fig. 4L). Like Six2, Pax2 expression in CM of Mi2b mutants was
reduced compared to wild-type kidneys (Fig. 4M, N). In contrast,
Pax2 expression was maintained in the UB of Mi2b mutant
kidneys. Consistent with this, there was also a reduction in the
number of Sall1-positive cells surrounding the UB tips of Mi2bD/Dalysis of protein expression at E12.5 and E14.5 of Cited1 (A, B, I, J), Six2 (C, D, K, L),
rrounding UB tips at E12.5 and E14.5 in wild type kidneys (A, I), however it was not
, Six2 was expressed in CM cells surrounding UB tips in both wild type andMi2bD/D
ells at E14.5 in Mi2bD/D kidneys compared to wild type (K,L). (E, F, M, and N) Pax2
in both wild type and Mi2bD/D kidneys (E, F). Its expression in UB was maintained
urrounding UB tips in Mi2bD/D kidneys compared to wild type at this stage (M, N).
type andMi2bD/D kidneys at E12.5 (G, H); however like Six2 and Pax2, there was a
idneys compared to wild type (O,P).
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the conclusion that renal progenitor cells form at the initial
stage of kidney development in Mi2b mutants, however their
progressive depletion contributes substantially to renal
hypoplasia.
Proliferation but not apoptosis is decreased in cap mesenchyme of
Mi2b mutants
Depletion of CM can be caused by an increase in apoptosis or a
decrease in proliferation. We thus analyzed whether apoptosis or
proliferation was altered in the CM lackingMi2b at E12.5–E14.5. We
quantiﬁed proliferation by immunostaining for phospho-histone H3
(pHH3) (Fig. 5A–E). The number of pHH3/Sall1 double positive cells
was related to the total number of Sall1-positive cells surrounding
UB tips in wild-type and Mi2bD/D mutant kidneys. At E12.5, there
was no signiﬁcant difference (p¼0.5) in the mitotic index of wild
type (1970.7%), andMi2b mutant kidneys (2170.6%). However, at
E13.5 there was signiﬁcant reduction (p¼0.01) in the mitotic index
in Mi2bD/D kidneys (1970.5%) compared with wild type controls
(3272.5%). A similar signiﬁcant reduction (p o0.001) in the
percentage of pHH3-positive cells of Mi2bD/D kidneys (1370.7%)
compared to the wild type (3670.7%) was also evident at E14.5
(Fig. 5E).
Apoptosis was measured by TUNEL assay in wild-type and
Mi2bD/D kidney sections in a similar fashion as proliferation. There
was no signiﬁcant difference (p¼0.5) in the number of cells
undergoing apoptosis in wild-type and Mi2bD/D kidneys at
E12.5, E13.5, and E14.5 (Fig. 5F and Supplementary Fig. 1S). These
results indicate that deﬁciency of Mi2b in renal progenitor cells
leads to decreased cell proliferation and does not signiﬁcantly
affect apoptosis. Importantly, the defect in cell proliferation was
detected at E13.5, preceding signiﬁcant overt renal hypoplasiaFig. 5. Proliferation but not apoptosis is decreased in Mi2b mutants. (A–D) Proliferatio
indicate CM cells that were scored as pHH3-positive. Sall1/pHH3 merged (A, C) and pHH
CM cells were counted and expressed as a percentage of the total number of Sall1-posit
kidneys (white bars). At E12.5 proliferation of CM cells was similar in wild type (1970
cells in Mi2bD/D kidneys. However, at E13.5 the percentage of proliferating cells was
littermates (A, B) (3272.5%) [n¼2, total of 250 cells counted in the wild type and 221
kidneys (1370.7%) compared to wild type (3670.7%) [n¼3, total of 208 cells counted
cells as measured by TUNEL assay (see Supplementary Fig. 1S) in E12.5, E13.5, and E14.5
difference in TUNEL-positive CM cells between wild-type and Mi2bD/D kidneys.and prior to a reduction in UB branching, suggesting it is
causative. This decrease in cell proliferation would be expected
to have a profound effect on the size of the progenitor pool as the
kidney grows.
Differentiated epithelial structures form but are reduced in number in
Mi2b mutants
Since the cells of the CM undergo mesenchymal-to-epithelial
transition [MET] (Kispert et al., 1998; Stark et al., 1994a) to form
the tubular segments of the nephron (Carroll et al., 2005), we next
analyzed whether that process was affected in Mi2bD/D kidneys.
We tested whether the MET occurred in the absence of Mi2b by
co-immunostaining wild type and Mi2bD/D kidneys for Mi2b and
proteins expressed in CM-derived differentiated structures. At
E15.5, renal vesicles co-expressed Mi2b and Lef1 in wild type
kidneys (Fig. 6A, C). While Lef1-positive structures were detected
in Mi2bD/D kidneys, they lacked Mi2b expression (Fig. 6B, D). Pax2
and Mi2bwere present in the CM, UB, and differentiated structures
of wild type kidneys (Fig. 6E,G), In contrast, inMi2bmutants, Mi2b
was only detected in Pax2-positive UB ofMi2bD/D kidneys, but was
absent from renal vesicles (Fig. 6F, H). Expression of Wnt4, a gene
required for MET (Stark et al., 1994b), was also detected by whole
mount in situ hybridization at E14 in Mi2bD/D mutants (Fig. 2S).
Together, these results indicate that Mi2b deﬁcient CM cells are
capable of undergoing MET to form Lef1- and Pax2-positve renal
vesicles.
Renal vesicles undergo morphological transitions and segmen-
tation into comma-and S-shaped bodies, and ultimately form all
of the nephron segments except the collecting duct (Faa et al.,
2012). To determine if Mi2b deﬁcient renal vesicles can form
more mature structures, we analyzed proteins that delineate the
stages of nephron development at E15.5 including: (1) NCAM andn of Sall1-positive CM cells as determined by pHH3 staining at E13.5. Arrowheads
3 staining alone (B, D) are shown. (E) Double-positive Sall1 (green) and pHH3 (red)
ive CM cells surrounding UB tips in E12.5–E14.5 wild type (black bars) and Mi2bD/D
.7%) and Mi2bD/D (2170.6%) [n¼2, total of 104 cells counted in wild type and 66
signiﬁcantly decreased in Mi2bD/D kidneys (1970.5%) compared with wild type
in Mi2bD/D kidneys]. Reduction in cell proliferation persisted at E14.5 in Mi2bD/D
for wild type and 200 cells for Mi2bD/D kidneys]. (F) Apoptosis of Sall1-positive CM
wild type (black bars) and Mi2bD/D kidneys (white bars). There was no signiﬁcant
Fig. 6. Differentiation of CM cells occurs despite the lack of Mi2b. (A–H) Identiﬁcation of renal vesicles in wild type and Mi2bD/D kidneys at E15.5 by immunostaining.
Co-localization of Mi2b (red) and Lef1 (green) was observed in renal vesicles of wild-type (A, C) kidneys. However, Lef1-positve renal vesicles inMi2bD/D kidneys (B) lacked
Mi2b expression (D). Pax2 and Mi2b were co-expressed in the CM, UB, and differentiated structures of wild type kidneys (E, G), In Mi2bD/D kidneys, Pax2-positive renal
vesicles (F) did not express Mi2b (H). In contrast, Mi2b expression was retained in the UB and stroma (A, D, F, H) in conditional mutant kidneys in whichMi2b is deleted in
CM by Six2-Cre.
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Fig. 7. Differentiated epithelial structures are reduced in number inMi2bD/D kidneys. (A–N) Immunoﬂuoresence and quantiﬁcation of differentiated structures in wild type
and Mi2bD/D kidneys at E15.5. NCAM (red) staining of wild type (A) and Mi2bD/D kidneys (B) revealed a decreased number of renal vesicles (arrowheads) and later
differentiated comma- and S-shaped bodies (asterisks) in Mi2bD/D kidneys (C). A similar reduction (F) was noted in the number of Lhx1-positive (red) differentiated
structures in Mi2bD/D kidneys (E) compared to wild type (D). WT1 (green) staining in wild type (G) and mutants (H) indicates that fewer glomeruli formed in Mi2bD/D
kidneys (I). Glomeruli that formed in mutants are smaller and showed an abnormal arrangement of the podocyte layer (G, H insets). Staining of LTL (green) and E-cadherin
(red) in wild type (J) and mutants (K) indicates that proximal and distal nephron segments formed (J, K insets) in Mi2b mutants, but their numbers were reduced (L).
E-cadherin-positive distal tubules were distinguished from UB epithelium by co-staining with cytokeratin which stains only UB (M, N).
D.R. Denner, M. Rauchman / Developmental Biology 375 (2013) 105–116112Lhx1, which mark early renal vesicles and comma- and S-shaped
bodies (Fujii et al., 1994; Klein et al., 1988), (2) WT1, which has
restricted expression to the developing podocytes in S-shapedbodies (Kreidberg, 2003), (3) LTL, which binds speciﬁcally to
proximal tubular segments, and (4) E-cadherin, which is
expressed in cytokeratin negative distal tubules.
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signiﬁcantly reduced (10.6771.52) compared to wild-type (20.257
0.84) (Fig. 7A–C). We noted a similar reduction in the number
of Lhx1-postive differentiated structures in the Mi2bD/D kidneys
(771.15) compared to wild type (1472) (Fig. 7D–F). Fewer WT1-
positive podocyte structures were formed in Mi2b mutants
(4.9770.86) compared to the wild-type (7.9170.61) (Fig. 7G–I).
WT1-positive structures were smaller andmorphologically abnormal
in the mutant (Fig. 7G, H inserts). Mi2bD/D kidneys were capable of
forming proximal and distal tubules as marked by E-cadherin and
LTL (Fig. 7K, inset) which were comparable to those seen in wild type
(Fig. 7J, inset). However, there were a signiﬁcant decrease in the
number of both LTL-positive proximal tubules (10.4371.02 vs.
24.7170.75) and E-cadherin-positive/cytokeratin-negative distalTable 1
Average kidney size to body weight ratio for Sall1/Mi2b compound mutants.
Genotype N Avg. KS/BW
WT 16 57.971.32
Sall1þ / 12 57.571.32
Mi2bD/þ 12 54.771.54
Sall1þ /Mi2bD/þ 14 41.871.04n
Mi2bD/D 13 38.471.63n
Sall1þ /Mi2bD/D 6 1870.29nn
n Po 0.01
nn Po0.001.
Fig. 8. Sall1 andMi2b genetically interact during embryonic kidney development. (A–D)
Cretg/þ , Mi2bﬂ/þ . Renal hypoplasia was seen in Sall1þ //Mi2bD/þ double heterozygotes
to Sall1þ / (A) and wild type (data not shown) mice. (E–L) Histological analysis of Sall1/M
in Sall1þ / /Mi2bD/þ double heterozygous kidneys (F, J); The loss of nephrogenic zone in
nephrogenic zone was not detected at this stage and there were rare differentiated struc
nephron precursor structures (E, I).tubules (10.1371.33 vs. 2571) in Mi2bD/D kidneys compared to
wild-type (Fig. 7J–N). Taken together, these results indicate that
while all nephron segments can form in Mi2b mutants, there is a
proportional decrease in nephron induction that is likely due
predominantly to the progressive depletion of CM progenitor cells.Sall1 and NuRD genetically interact during kidney development
We have previously demonstrated that Sall1 and Mi2–NuRD
associate to regulate developmental gene expression in Xenopus
embryos and in a cell culture model (Lauberth et al., 2007;
Lauberth and Rauchman, 2006). We thus hypothesized that
NuRD’s role in developing kidney would involve its interaction
with the transcription factor Sall1, an essential gene in nephro-
genesis. To test for a functional interaction in vivo, we examined
whether the Mi2b mutant phenotype was sensitive to a genetic
reduction of Sall1 dose by crossing Mi2b mutants with Sall1þ /
heterozygous mice. Both Sall1 and Mi2b single heterozygous
mutant mice had normal kidneys. Average kidney area to body
weight ratios for Sall1þ / (57.571.32) and Mi2bD/þ (54.771.53)
were not signiﬁcantly different than wild-type littermates (57.97
1.32). However, double heterozygous Sall1þ /Mi2bD/þ mice exhib-
ited signiﬁcant renal hypoplasia. The average kidney area to body
weight ratio for double heterozygotes (41.871.04) was signiﬁ-
cantly smaller than wild type and single heterozygous mice, andE15.5 kidneys dissected from genetic crosses between Sall1þ / ,Mi2bﬂ/þ and Six2-
(B) and even more prominently in Mi2bD/D (C) and Sall1þ / , Mi2bD/D (D) compared
i2b compound mutants. Thickness of the nephrogenic zone (bracket) was reduced
Mi2bD/D kidneys was more severe (G, K). In Sall1þ / , Mi2bD/D mutant kidneys the
tures (H, L). Sall1þ / kidneys had a normal nephrogenic zone with many epithelial
D.R. Denner, M. Rauchman / Developmental Biology 375 (2013) 105–116114comparable toMi2bD/D homozygous mutants (38.471.63) (Table 1
and Fig. 8B–D).
Deletion of both Mi2b alleles from the CM cells in the Sall1
heterozygous mutant background further worsened the kidney
phenotype. Renal hypoplasia in these mutant mice was consider-
ably more severe than that of Sall1, Mi2b double heterozygous or
Mi2bD/D homozygous mutants alone (average kidney area to body
weight of 1870.29) (Fig. 8E).
We performed histological staining of these compound mutants
to further characterize the renal hypoplasia. Examination of E15.5
Sall1þ /Mi2bD/þ kidneys revealed a moderate reduction in the
thickness of the nephrogenic zone and fewer differentiated struc-
tures compared to wild-type and Sall1þ / controls (Fig. 8F, J). Some
tubules and glomeruli exhibited cystic dilation, indicating abnorm-
alities in the differentiation process. Histological analysis ofMi2bD/D
kidneys revealed a slightly more severe reduction in the size of the
nephrogenic zone compared to Sall1þ /Mi2bD/þ kidneys (Fig. 8G, K).
In Sall1þ /Mi2bD/D mutant kidneys, no demarcated nephrogenic
zone existed, with near complete loss of CM and presence of only
rare differentiated structures (Fig. 8H, L). The renal medulla
formed in these compound mutants with a reduction in size that
is comparable to the overall decrease in the kidney. These results
demonstrate a strong, dose dependent genetic interaction
between Sall1 and Mi2b, suggesting that they act cooperatively
to regulate kidney development.Discussion
These results provide the ﬁrst demonstration that Mi2b, a key
component of the NuRD complex is required for normal kidney
development. Speciﬁc deletion of Mi2b in CM affects the prolif-
eration of renal progenitor cells leading to renal hypoplasia. Mi2b
and Sall1 display a strong genetic interaction indicating that they
cooperate in formation of the kidney.
Kidney development is an iterative process leading to induc-
tion of thousands of individual functional units, called nephrons.
Thus, growth of the kidney depends on a dramatic expansion of
the progenitor pool. Our studies provide insight into the control of
this process by showing that Mi2b is required for maintenance
and expansion of these cells. In the absence ofMi2b, the ability for
sustained or extended proliferative capacity necessary for devel-
opment of a normal complement of nephrons was critically
dependent on the presence of Mi2b. This conclusion is supported
by several lines of evidence showing that the CM defects preceded
the depletion of these progenitor cells and the development of an
overt renal hypoplasia phenotype ﬁrst noted at E14.5. These
observations include speciﬁc loss of Cited1 expression in CM at
E12.5 (Fig. 4B), reduced CM cell proliferation at E13.5 (Fig. 5E),
with no detectable increase in apoptosis (Fig. 5F). In addition, UB
branching was not reduced in the mutant at E13.5 (Fig. 3C).
Together these results support the conclusion that the loss of
proliferative capacity of Mi2b deﬁcient CM is a principal cause of
severe hypoplasia in these mutants.
In addition to the CM, Mi2b is expressed broadly in the
developing kidney, including various stages of nephron precur-
sors, and speciﬁc deletion of Mi2b in CM removes this gene from
all nephron structures derived from these progenitor cells. Thus,
Mi2b could have functions at several steps of kidney develop-
ment, apart from a critical role in CM growth, which could
contribute to renal hypoplasia. We addressed this possibility by
examining nephron formation in Mi2b mutants. We observed a
severe reduction of nephron number in Mi2b mutants, resulting
in peri-natal lethality. This was associated with a reduction in
renal vesicle formation, the earliest morphological precursor of
the nephron, and by a proportionate decrease in all the moreterminally differentiated segments of the nephron (Fig. 7). Our
studies show that Lef1-positive renal vesicles (RVs) that formed in
the mutant were composed of Mi2b deﬁcient cells (Fig. 6B, D),
indicating that Mi2b is not required for mesenchymal-to-
epithelial transition (MET). We cannot exclude the possibility,
however, that the efﬁciency of MET is impaired by loss of Mi2b
and thereby contributed to reduced RV formation. Our studies
also revealed that podocyte precursors, as well as proximal and
distal tubules formed, albeit in reduced numbers, in the Mi2b
mutants. This suggests that segmentation of the nephron was not
overtly impaired by loss of Mi2b. Overall, these analyses of
nephron formation are consistent with our model that reduced
renal progenitor cell proliferation is the predominant cause of
renal hypoplasia due to deletion of Mi2b in CM by Six2-Cre.
However, our studies may have also uncovered a speciﬁc role
for Mi2b in the proper differentiation of nephrons. While Wt1-
positive glomeruli formed inMi2b deﬁcient kidneys, the podocyte
layer was disorganized (Fig. 7H, inset). This suggests that Mi2b
may be required for the developmental transition from the
precursor epithelial structure (renal vesicle) to formation of the
most proximal segment of the nephron (glomerulus). Sall1 is
highly expressed in renal vesicles and its interaction with Mi2ß in
this structure, rather than in CM, could account for the patterning
defect we observed in podocytes. Consistent with this idea,
Mi2b, Sall1 compound heterozygotes also displayed evidence of
abnormal nephron development, including cystic dilatation of
glomeruli and renal tubules (Fig. 8K). These compound mutants
died of kidney failure at 6–8 weeks indicating the severity of this
defect. Future studies using other informative Cre strains could be
used to bypass the requirement ofMi2b in CM and more precisely
deﬁne its role in segment or cell type speciﬁc speciﬁcation of
renal epithelial cells.
Six2, a gene that is required to maintain renal progenitors, was
reduced in Mi2b deﬁcient CM. In Six2 mutant kidneys, premature
differentiation and apoptosis of CM is thought to account for
progenitor cell depletion (Self et al., 2006). Mi2b mutants did not
display premature differentiation (Fig. 4E–H and data not shown)
or increased apoptosis. In contrast, the profound reduction in cell
proliferation that we observed in Mi2b mutant kidneys can likely
account for the progressive depletion of CM, suggesting a differ-
ent molecular mechanism than the one proposed for Six2. Recent
studies show that canonical Wnt signaling is required for main-
tenance and proliferation of progenitor cells (Karner et al., 2011).
Since both Mi2–NuRD and Sall1 have been shown to modulate
Wnt activity (Kiefer et al., 2010; Moon, 2004; Sato et al., 2004), we
speculate that their cooperative action in the kidney could
regulate renal progenitors through this pathway.
While Mi2 has been postulated to have effects independent
(Kunert and Brehm, 2009) of its association with the NuRD
complex, it is likely that its role in renal progenitor cells is
NuRD-dependent. We have previously shown that Sall1 physi-
cally associates with NuRD to directly regulate gene expression
(Lauberth et al., 2007; Lauberth and Rauchman, 2006). Analysis of
Sall1þ /; Mi2bD/D compound mutants showed a more profound
degree of renal hypodysplasia, accompanied by a severe depletion
of CM, indicating that they act cooperatively to maintain renal
progenitors. The strong genetic interaction in the kidney between
Sall1 and Mi2b described in this study likely relates to function of
the NuRD complex. In support of this conclusion, we have
recently found that disruption of the Sall1-NuRD interaction
in vivo leads to severe renal hypodysplasia (Denner & Rauchman,
manuscript in preparation). NuRD has been shown to inﬂuence
gene expression at the level of chromatin either through its direct
association with DNA, binding of pre-existing histone modiﬁca-
tions or through its recruitment of sequence-speciﬁc DNA binding
factors such as Ikaros, Fog1 and Bcl11a (Cismasiu et al., 2005;
D.R. Denner, M. Rauchman / Developmental Biology 375 (2013) 105–116 115Hong et al., 2005; Lai and Wade, 2011). Elegant studies from the
Georgopoulos laboratory suggest a model whereby proper targeting
of the Mi2–NuRD complex through its interaction with lineage
speciﬁc DNA binding factors, such as Ikaros, is essential for the
balance between growth and differentiation of progenitors
(Zhang et al., 2012). In ES cells, Sall4 and NuRD are found in a
macromolecular complex that has been shown to regulate plur-
ipotency and lineage determination (Liang et al., 2008). Our
studies raise the intriguing possibility that Sall1-NuRD similarly
act together to control speciﬁc target genes in renal progenitors
that affect the timely induction of renal vesicles versus the
decision to proliferate and thereby expand the progenitor pool.
Future genome-wide analyses of Sall1 and NuRD chromatin
binding and transcriptional proﬁling will be needed to deﬁne
the epigenetic regulation of nephron induction versus progenitor
cell self-renewal in developing kidney.
Renal hypodysplasia, similar to that observed in Mi2b, Sall1
compound heterozygous mutants, is a common birth defect that
accounts for40% of childhood renal failure (Cain et al., 2010).
Thus it is important to identify genetic pathways that lead to
these disorders and that could be manipulated therapeutically to
increase nephron formation. HDAC inhibitors and agents targeting
other chromatin modifying enzymes are now being tested for the
treatment of various diseases, especially cancers. Understanding the
role of chromatin remodeling complexes in the epigenetic regula-
tion of pathways that control nephron number has the potential to
produce novel approaches to these common birth defects.Acknowledgments
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